BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9891188)

  • 1. Contingent negative variation in migraine: effect of beta blocker therapy.
    Ahmed I
    Clin Electroencephalogr; 1999 Jan; 30(1):21-3. PubMed ID: 9891188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contingent negative variation and efficacy of beta-blocking agents in migraine.
    Schoenen J; Maertens de Noordhout A; Timsit-Berthier M; Timsit M
    Cephalalgia; 1986 Dec; 6(4):229-33. PubMed ID: 2879628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.
    Jackson JL; Kuriyama A; Kuwatsuka Y; Nickoloff S; Storch D; Jackson W; Zhang ZJ; Hayashino Y
    PLoS One; 2019; 14(3):e0212785. PubMed ID: 30893319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingent negative variation in headache.
    Maertens de Noordhout A; Timsit-Berthier M; Timsit M; Schoenen J
    Ann Neurol; 1986 Jan; 19(1):78-80. PubMed ID: 3947039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of the study of contingent negative variation in migraine and tension headache].
    Timsit M; Timsit-Berthier M; Schoenen J; Maertens de Noordhout A
    Rev Electroencephalogr Neurophysiol Clin; 1987 Sep; 17(3):259-70. PubMed ID: 3317575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of contingent negative variation between migraine interval and migraine attack before and after treatment with sumatriptan.
    Göbel H; Krapat S; Ensink FB; Soyka D
    Headache; 1993; 33(10):570-2. PubMed ID: 8294198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contingent negative variation in patients with chronic daily headache.
    Siniatchkin M; Gerber WD; Kropp P; Vein A
    Cephalalgia; 1998 Oct; 18(8):565-9; discussion 531. PubMed ID: 9827249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta blockers and the central nervous system.
    Schoenen J
    Cephalalgia; 1986; 6 Suppl 5():47-54. PubMed ID: 2879632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contingent negative variation in childhood migraine.
    Besken E; Pothmann R; Sartory G
    Cephalalgia; 1993 Feb; 13(1):42-3. PubMed ID: 8448788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contingent negative variation--findings and perspectives in migraine.
    Kropp P; Gerber WD
    Cephalalgia; 1993 Feb; 13(1):33-6. PubMed ID: 8448786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contingent negative deviation in children with headaches].
    Cherniak ZV; Zenkov LR; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(6):19-24. PubMed ID: 12872621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack.
    Kropp P; Gerber WD
    Cephalalgia; 1995 Apr; 15(2):123-8; discussion 78-9. PubMed ID: 7641246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive muscle relaxation reduces migraine frequency and normalizes amplitudes of contingent negative variation (CNV).
    Meyer B; Keller A; Wöhlbier HG; Overath CH; Müller B; Kropp P
    J Headache Pain; 2016; 17():37. PubMed ID: 27090417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
    Goncalves DA; Camparis CM; Speciali JG; Castanharo SM; Ujikawa LT; Lipton RB; Bigal ME
    J Orofac Pain; 2013; 27(4):325-35. PubMed ID: 24171182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta-adrenergic inhibitors and migraine].
    Dubois B; Bousser MG
    Therapie; 1985; 40(6):407-12. PubMed ID: 2868536
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of migraine attacks using a slow cortical potential, the contingent negative variation.
    Kropp P; Gerber WD
    Neurosci Lett; 1998 Nov; 257(2):73-6. PubMed ID: 9865930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study.
    Siniatchkin M; Andrasik F; Kropp P; Niederberger U; Strenge H; Averkina N; Lindner V; Stephani U; Gerber WD
    Cephalalgia; 2007 Sep; 27(9):1024-32. PubMed ID: 17680819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of age-dependent development of the contingent negative variation (CNV) in migraine children?
    Bender S; Weisbrod M; Just U; Pfüller U; Parzer P; Resch F; Oelkers-Ax R
    Cephalalgia; 2002 Mar; 22(2):132-6. PubMed ID: 11972581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease duration of episodic migraine correlates with modified amplitudes and habituation of contingent negative variation.
    Kropp P; Wallasch TM; Müller B; Meyer B; Darabaneanu S; Bosse C; Keller A; Meyer W; Gerber WD
    J Neural Transm (Vienna); 2015 Jun; 122(6):877-85. PubMed ID: 25432434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test.
    Smits MG; van der Meer YG; Pfeil JP; Rijnierse JJ; Vos AJ
    Headache; 1994 Feb; 34(2):103-6. PubMed ID: 8163364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.